Monday, August 25, 2025
HomeIndustriesBiotechnology

Biotechnology

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of the BRIGHT Phase III Clinical Trial Evaluating PRX-102 for the Treatment of Fabry...

Protalix BioTherapeutics, Inc. a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell‑based...

Ionis Announces Publication of Positive Phase 2 Data for Donidalorsen in New England Journal of Medicine

Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapies, announced the publication of positive Phase 2 data for donidalorsen (formerly IONIS-PKK-LRx) in the New England...

Biocom California Purchasing Group Announces LeggUP as New Professional Development Partner

Biocom California Purchasing Group, the group purchasing organization serving California's largest life science membership association, announced a new partnership with LeggUP – a professional...

Stealth BioTherapeutics Showcases New Duchenne Muscular Dystrophy Nonclinical Data at the 2022 Muscular Dystrophy Association and Clinical Scientific Conference

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today presented...

I Peace Triples GMP Cell Manufacturing by Expanding CDMO Facility

I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech start-up, announced that the company had tripled its capacity to manufacture GMP grade iPS...
0FansLike
0FollowersFollow
spot_img

Hot Topics